Loading...
Loading...
JP Morgan published a research report today providing color on Abbott Laboratories'
ABT 4Q earning results. The investment firm has a Neutral rating on Abbott Laboratories.
In the report, JP Morgan writes, "Abbott reported 4Q results this morning that were mostly in line with Street consensus. EPS of $1.45 (+11.8%) were a penny above consensus and in line with our thinking. Revenues of $10.377B were up 4.1% reported and 3.8% organic. On a reported basis, sales were $253M below the Street and $112M below our forecast"
Shares of Abbott Laboratories are currently trading at $55.04, down 1.68% from yesterday's close.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst Ratings
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in